DE69432976D1 - Verffahren zum überwachen der befolgung einer vorgeschriebenen medikation durch einen patienten - Google Patents

Verffahren zum überwachen der befolgung einer vorgeschriebenen medikation durch einen patienten

Info

Publication number
DE69432976D1
DE69432976D1 DE69432976T DE69432976T DE69432976D1 DE 69432976 D1 DE69432976 D1 DE 69432976D1 DE 69432976 T DE69432976 T DE 69432976T DE 69432976 T DE69432976 T DE 69432976T DE 69432976 D1 DE69432976 D1 DE 69432976D1
Authority
DE
Germany
Prior art keywords
urine
medication
patient
medication concentration
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69432976T
Other languages
English (en)
Inventor
Michael Kell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
U D Testing Inc
Original Assignee
U D Testing Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26843316&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69432976(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/145,821 external-priority patent/US6124136A/en
Priority claimed from US08/248,102 external-priority patent/US5547878A/en
Application filed by U D Testing Inc filed Critical U D Testing Inc
Application granted granted Critical
Publication of DE69432976D1 publication Critical patent/DE69432976D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/816—Alkaloids, amphetamines, and barbiturates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/901—Drugs of abuse, e.g. narcotics, amphetamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/17—Nitrogen containing
    • Y10T436/173845—Amine and quaternary ammonium
DE69432976T 1993-11-02 1994-10-19 Verffahren zum überwachen der befolgung einer vorgeschriebenen medikation durch einen patienten Expired - Lifetime DE69432976D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/145,821 US6124136A (en) 1993-11-02 1993-11-02 Method of monitoring compliance with methadone treatment program
US08/248,102 US5547878A (en) 1993-11-02 1994-05-24 Method of monitoring patient compliance with medications prescriptions
PCT/US1994/012119 WO1995012812A1 (en) 1993-11-02 1994-10-19 Method of monitoring patient compliance with medications prescriptions

Publications (1)

Publication Number Publication Date
DE69432976D1 true DE69432976D1 (de) 2003-08-28

Family

ID=26843316

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69432976T Expired - Lifetime DE69432976D1 (de) 1993-11-02 1994-10-19 Verffahren zum überwachen der befolgung einer vorgeschriebenen medikation durch einen patienten

Country Status (8)

Country Link
US (2) US5652146A (de)
EP (1) EP0748444B1 (de)
JP (1) JP4389005B2 (de)
AT (1) ATE245814T1 (de)
AU (1) AU698403B2 (de)
CA (1) CA2175584C (de)
DE (1) DE69432976D1 (de)
WO (1) WO1995012812A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955370A (en) * 1993-11-02 1999-09-21 U.D. Testing, Inc. Urine adulteration test method
US5602038A (en) * 1994-07-25 1997-02-11 Private Clinic Laboratories, Inc. Method of determining renal clearances
JP3592822B2 (ja) * 1996-01-23 2004-11-24 株式会社いかがく 採取尿の保存方法および採尿用キット
US6587829B1 (en) * 1997-07-31 2003-07-01 Schering Corporation Method and apparatus for improving patient compliance with prescriptions
US6421650B1 (en) * 1998-03-04 2002-07-16 Goetech Llc Medication monitoring system and apparatus
US20040062802A1 (en) * 1998-04-02 2004-04-01 Hermelin Victor M. Maximizing effectiveness of substances used to improve health and well being
US5945123A (en) * 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
US6397190B1 (en) * 1998-07-22 2002-05-28 Gerald E. Goetz Veterinary medication monitoring system and apparatus
US7069227B1 (en) 1999-02-05 2006-06-27 Zansor Systems, Llc Healthcare information network
US7069226B1 (en) * 1999-07-07 2006-06-27 Synetic, Incorporated Prescription data processing system for determining new therapy starts
CA2390261C (en) * 1999-11-08 2014-04-22 University Of Florida Research Foundation, Inc. Marker detection method and apparatus to monitor drug compliance
US20030194374A1 (en) * 2001-01-17 2003-10-16 Xanodyne Pharmacal, Inc. Compositions including a visual marker and method of use thereof
US7062312B2 (en) * 2001-01-17 2006-06-13 Pediamed Pharmaceuticals, Inc. Combination and method including a visual marker for determining compliance with a medication regimen
US20020143579A1 (en) * 2001-03-30 2002-10-03 Docherty John P. System and method for targeted interventions of physician prescription practices based on deviations from expert guidelines
US8065180B2 (en) 2001-04-02 2011-11-22 invivodata®, Inc. System for clinical trial subject compliance
US7415447B2 (en) * 2001-04-02 2008-08-19 Invivodata, Inc. Apparatus and method for prediction and management of participant compliance in clinical research
US8533029B2 (en) 2001-04-02 2013-09-10 Invivodata, Inc. Clinical monitoring device with time shifting capability
US7873589B2 (en) * 2001-04-02 2011-01-18 Invivodata, Inc. Operation and method for prediction and management of the validity of subject reported data
US20030110060A1 (en) * 2001-12-12 2003-06-12 Clementi William A. Method of providing comprehensive drug compliance information
US7585680B2 (en) * 2003-08-28 2009-09-08 Marshfield Medical Research And Education Foundation Method and device for monitoring medication usage
CA2538661A1 (en) * 2003-09-19 2005-03-31 Tag, Llc Method for competitive prescription drug and/or bidding service provider selection
US8781857B2 (en) 2003-09-19 2014-07-15 Tag, Llc Method for competitive prescription drug and/or bidding service provider selection
US20060184473A1 (en) * 2003-11-19 2006-08-17 Eder Jeff S Entity centric computer system
AU2005264864B2 (en) 2004-06-16 2011-08-11 Takeda Pharmaceutical Company Limited Multiple PPI dosage form
US8296162B1 (en) 2005-02-01 2012-10-23 Webmd Llc. Systems, devices, and methods for providing healthcare information
CN101432772A (zh) * 2006-03-01 2009-05-13 泰戈公司 用于竞争的处方药物和/或投标服务提供者选择的方法
WO2008020325A2 (en) * 2006-06-01 2008-02-21 Rajiv Muradia Home based healthcare system and method
WO2008053366A2 (en) * 2006-06-01 2008-05-08 Rajiv Muradia Remote health care diagnostic tool
CA2653346A1 (en) * 2006-06-01 2007-12-06 Igeacare Systems, Inc. Remote health care system with treatment verification
WO2008035211A2 (en) * 2006-06-01 2008-03-27 Rajiv Muradia Remote health care system with stethoscope
JP2010511941A (ja) * 2006-12-01 2010-04-15 アメリトックス リミテッド 毒性学的報告書を生成する方法及び装置
KR100867324B1 (ko) 2007-03-13 2008-11-06 가톨릭대학교 산학협력단 혈중약물농도측정 처방 자동화 방법
AU2008310735B2 (en) 2007-10-12 2013-09-12 Takeda Pharmaceutical Company Limited Methods of treating gastrointestinal disorders independent of the intake of food
US8380531B2 (en) * 2008-07-25 2013-02-19 Invivodata, Inc. Clinical trial endpoint development process
JP2012500403A (ja) * 2008-08-18 2012-01-05 ベックマン コールター， インコーポレイテッド 正規化された１０進相当システムおよび方法
WO2011099985A1 (en) * 2010-02-11 2011-08-18 Harry Leider Methods of normalizing measured drug concentrations and testing for non-compliance with a drug treatment regimen
ES2544873T3 (es) * 2010-02-11 2015-09-04 Ameritox Limited Partnership Métodos para normalizar las concentraciones de oxicodona medidas y los ensayos para un incumplimiento de un régimen de tratamiento
SG183354A1 (en) * 2010-03-05 2012-09-27 Braun Melsungen Ag System and method for administering medicaments on the basis of urine values
US10276054B2 (en) 2011-11-29 2019-04-30 Eresearchtechnology, Inc. Methods and systems for data analysis
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US9858063B2 (en) 2016-02-10 2018-01-02 Vignet Incorporated Publishing customized application modules
US9928230B1 (en) 2016-09-29 2018-03-27 Vignet Incorporated Variable and dynamic adjustments to electronic forms
US10775974B2 (en) 2018-08-10 2020-09-15 Vignet Incorporated User responsive dynamic architecture
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
US20210215662A1 (en) * 2020-01-15 2021-07-15 MX3 Diagnostics, Inc. Assessment of biomarker concentration in a fluid
US11328796B1 (en) 2020-02-25 2022-05-10 Vignet Incorporated Techniques for selecting cohorts for decentralized clinical trials for pharmaceutical research
US11461216B1 (en) 2020-05-18 2022-10-04 Vignet Incorporated Monitoring and improving data collection using digital health technology
US11605038B1 (en) 2020-05-18 2023-03-14 Vignet Incorporated Selecting digital health technology to achieve data collection compliance in clinical trials
US11763919B1 (en) 2020-10-13 2023-09-19 Vignet Incorporated Platform to increase patient engagement in clinical trials through surveys presented on mobile devices
US11417418B1 (en) 2021-01-11 2022-08-16 Vignet Incorporated Recruiting for clinical trial cohorts to achieve high participant compliance and retention
US11240329B1 (en) 2021-01-29 2022-02-01 Vignet Incorporated Personalizing selection of digital programs for patients in decentralized clinical trials and other health research
US11296971B1 (en) 2021-02-03 2022-04-05 Vignet Incorporated Managing and adapting monitoring programs
US11789837B1 (en) 2021-02-03 2023-10-17 Vignet Incorporated Adaptive data collection in clinical trials to increase the likelihood of on-time completion of a trial
US11586524B1 (en) 2021-04-16 2023-02-21 Vignet Incorporated Assisting researchers to identify opportunities for new sub-studies in digital health research and decentralized clinical trials
US11521714B1 (en) 2021-02-03 2022-12-06 Vignet Incorporated Increasing diversity of participants in health research using adaptive methods
US11196656B1 (en) 2021-02-03 2021-12-07 Vignet Incorporated Improving diversity in cohorts for health research
US11281553B1 (en) 2021-04-16 2022-03-22 Vignet Incorporated Digital systems for enrolling participants in health research and decentralized clinical trials
US11361846B1 (en) 2021-02-03 2022-06-14 Vignet Incorporated Systems and methods for customizing monitoring programs involving remote devices
US11316941B1 (en) 2021-02-03 2022-04-26 Vignet Incorporated Remotely managing and adapting monitoring programs using machine learning predictions
US11636500B1 (en) 2021-04-07 2023-04-25 Vignet Incorporated Adaptive server architecture for controlling allocation of programs among networked devices
US11901083B1 (en) 2021-11-30 2024-02-13 Vignet Incorporated Using genetic and phenotypic data sets for drug discovery clinical trials
US11705230B1 (en) 2021-11-30 2023-07-18 Vignet Incorporated Assessing health risks using genetic, epigenetic, and phenotypic data sources
CN114371238A (zh) * 2022-01-11 2022-04-19 中国水产科学研究院长江水产研究所 一种生产状态下水产动物休药期的测定方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2564247A (en) * 1947-08-18 1951-08-14 Richard M Carson Method of testing urine to determine pregnancy
US3856469A (en) * 1973-01-02 1974-12-24 Syva Corp Interferant removal from amphetamine immunoassay
US3901655A (en) * 1973-12-26 1975-08-26 American Cyanamid Co Urine toxicology control
US4104367A (en) * 1976-10-13 1978-08-01 Hoffmann-La Roche Inc. Radioimmunoassay for methadone
US4196185A (en) * 1978-06-05 1980-04-01 Hoffmann-La Roche Inc. Immunoassay for phencyclidine
JPH0698032B2 (ja) * 1987-01-23 1994-12-07 財団法人野田産業科学研究所 クレアチンもしくはクレアチニンの測定法及びこれらの測定用試薬
US5137692A (en) * 1990-12-11 1992-08-11 Robert Fritz Nitrogen test kit for physical training
US5179027A (en) * 1991-01-10 1993-01-12 Fisher Murray M Method employing chemical markers and kit for verifying the source and completeness of urine samples for testing for the presence of drugs of abuse
US5547878A (en) * 1993-11-02 1996-08-20 Kell; Michael Method of monitoring patient compliance with medications prescriptions

Also Published As

Publication number Publication date
EP0748444A1 (de) 1996-12-18
AU8087394A (en) 1995-05-23
US5652146A (en) 1997-07-29
US5908788A (en) 1999-06-01
CA2175584C (en) 2005-07-12
EP0748444B1 (de) 2003-07-23
ATE245814T1 (de) 2003-08-15
JPH09508967A (ja) 1997-09-09
JP4389005B2 (ja) 2009-12-24
CA2175584A1 (en) 1995-05-11
AU698403B2 (en) 1998-10-29
EP0748444A4 (de) 1997-08-27
WO1995012812A1 (en) 1995-05-11

Similar Documents

Publication Publication Date Title
DE69432976D1 (de) Verffahren zum überwachen der befolgung einer vorgeschriebenen medikation durch einen patienten
Meehl et al. Taxometric analysis: I. Detecting taxonicity with two quantitative indicators using means above and below a sliding cut (MAMBAC procedure).
FR2631708B1 (fr) Dispositif permettant d'effectuer des mesures ou des interventions dans un puits, methode utilisant le dispositif et applications du dispositif
DE69507019D1 (de) Speicheltestverfahren und vorrichtung
NO961810L (no) Bestemmelse av glukoseinnholdet i en biologisk matriks
DE60127262D1 (de) Verfahren und vorrichtung zum überwachen von materialermüdung
DE3867774D1 (de) Vorrichtung zur ueberwachung des kritischen zustandes und messung der konzentration spaltbarer massen.
DE3485653D1 (de) Verfahren und vorrichtung zur messung des reaktionsgrades zwischen antigenen und zell-leukozytenantikoerpern.
DE69024677D1 (de) Verfahren und Vorrichtung zur Überwachung des Ovulationszyklus
DE69402307D1 (de) Verfahren und vorrichtung zum ermitteln der schnellwerte des wahrnehmungsvermögens einer prüfperson für visuelle reize
ATE255726T1 (de) Verfahren zur vorhersage von frühgeburten
DE68904669D1 (de) Verfahren zur ueberwachung von ungewoehnlichen anzeichen in gasgefuellten vorrichtung sowie gasgefuellte vorrichtung mit ueberwacher.
CA2119888A1 (en) Blood alcohol monitor
DE59608232D1 (de) Verfahren und Vorrichtung zum Erfassen von Belastungen von Hub- und Zugeinrichtungen
JPS646847A (en) Chemical analysis apparatus
ATE513212T1 (de) Einfache methoden zum drug monitoring von gpiib/iiia-rezeptor-antagonisten
DE59814256D1 (de) Verfahren und Vorrichtung zum manuellen Erfassen unterschiedlicher Ereignisse oder Zustände
FR2564894B2 (fr) Methode et dispositif permettant d'effectuer des mesures et/ou interventions dans un puits.
EP0628820A3 (de) Diagnose und Überwachung von Patienten mit Dickdarmkrebs durch Messung von NCA 50/90 im Blut.
Magos Biological methods of defining human exposures.
EP0621480A3 (de) Diagnose und Überwachung von Patienten mit Lungenkrebs durch Messung von NCA 50/90 im Blut.
JPS57198870A (en) Tester for anemometer
JPS52135794A (en) Automatic chemical analyzer
BE880302A (fr) Dispositif permettant de realiser le pontage des joints ou fissures en une seule operation et son procede d'application
JPS53142259A (en) Threshold condition testing system

Legal Events

Date Code Title Description
8332 No legal effect for de